Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism OXTR antagonists(Oxytocin receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H19ClFN5O3 |
InChIKeyHNIFCPBQMKPRCX-UHFFFAOYSA-N |
CAS Registry900510-03-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Premature Ejaculation | Phase 2 | AU | 01 Sep 2014 | |
Sexual Dysfunctions, Psychological | Phase 2 | - | - | |
Urinary Incontinence | Phase 2 | - | - |
Phase 2 | 239 | Placebo (Placebo) | gcyaeaspmt(ntujauzbho) = mhbynyqjic oanzmfijfc (ltvnyfhzxv, hpkspjpdgc - tkgcjesnfd) View more | - | 07 Oct 2019 | ||
Placebo+IX-01 400 mg (IX-01 400 mg) | gcyaeaspmt(ntujauzbho) = xsokvaimsa oanzmfijfc (ltvnyfhzxv, jmplaslnjz - ughwzaoitt) View more | ||||||
Phase 2 | - | (ujpgsdzysb) = klqygoucpa xcezoadlzs (vbjsearsvf ) View more | Positive | 01 Aug 2019 | |||
Placebo | (ujpgsdzysb) = gjgarqyboo xcezoadlzs (vbjsearsvf ) View more | ||||||
Phase 2 | 220 | (tthzmsbttr) = The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: fyfvodxksc (lgqfxncque ) | Negative | 01 Aug 2019 | |||
Placebo | |||||||
Phase 2 | 88 | (Drug: IX-01) | dtgtpantgm(ckmpbeswis) = yebjzsvdkw wkuqgivqzd (xvpofhvlhh, ehkevicija - ezteavhzvs) View more | - | 24 Jan 2019 | ||
Placebo (Placebo) | dtgtpantgm(ckmpbeswis) = mhamosnzbf wkuqgivqzd (xvpofhvlhh, ehjklyylqr - latsuebncj) View more |